Effects of Treatment with Pentoxifylline on the Cardiovascular Manifestations of Group B Streptococcal Sepsis in the Piglet1
- 1 September 1996
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 40 (3) , 469-474
- https://doi.org/10.1203/00006450-199609000-00017
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis SyndromeJAMA, 1995
- Pilot Study of Cardiopulmonary Risk from Pentoxifylline in Adult Respiratory Distress SyndromeChest, 1993
- Effects of Pentoxifylline on the Cardiovascular Manifestations of Group B Streptococcal Sepsis in the PigletPediatric Research, 1992
- Group BStreptococcusInduces Tumor Necrosis Factor in Neonatal Piglets: Effect of the Tumor Necrosis Factor Inhibitor Pentoxifylline on Hemodynamics and Gas ExchangeAmerican Review of Respiratory Disease, 1991
- Attenuation of Tumor Necrosis Factor-induced Endothelial Cell Cytotoxicity and Neutrophil ChemiluminescenceAmerican Review of Respiratory Disease, 1990
- Tumor Necrosis Factor-Induced Neonatal Pulmonary Hypertension: Effects of Dazmegrel PretreatmentPediatric Research, 1990
- Pentoxifylline Prevents Tumor Necrosis Factor-induced Lung InjuryAmerican Review of Respiratory Disease, 1989
- Cachetin/TNF-α in Septic Shock and Septic Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1988
- Antithrombotic Potential of Pentoxifylline A Hemorheologically Active DrugAngiology, 1985
- Cardiovascular effects of aminophylline and pentoxifylline on intact dogs and isolated dog atria.Japanese Heart Journal, 1982